Attention deficit hyperactivity disorder (ADHD) sufferers could be getting more than they bargained for from drugs prescribed to relieve their symptoms. The FDA ordered that labels on certain ADHD medications indicate a possibility of psychiatric side effects. A category of ADHD drugs that includes Concerta and Ritalin has caused reported hallucinations, suicidal thoughts and psychotic behavior as well as aggression and violent actions.
The FDA also plans to investigate the connection between cardiovascular concerns and ADHD drugs after some Concerta users reported hypertension, chest pain, arrhythmias and rapid heart beat.
In the U.S., roughly 7.8 million prescriptions were filled for Concerta. The FDA estimates about six million of those prescriptions were filled for people 16 years old and younger.
An FDA investigation into possible psychiatric side effects of competing ADHD drugs, such as amphetamines, which include Adderall and Strattera, is also planned.
For more information about dangerous drugs, visit the Recalled Drugs and Other Drug Alerts Legal Center.